OBI-3424 Uses, Dosage, Side Effects and more

OBI-3424 is under investigation in clinical trial NCT04315324 (Study to Test Akr1c3-activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/refractory T-cell Acute Lymphoblastic Leukemia (T-ALL)).

Trade Name OBI-3424
Generic OBI-3424
Type
Formula C21H25N4O6P
Weight Average: 460.427
Monoisotopic: 460.151171539
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share